查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1519354

2024-2032 年按类型、原料（猪肉、牛肉、骨头、羟丙基甲基纤维素等）、功能、治疗应用、最终用户和地区分類的空胶囊市场报告

Empty Capsules Market Report by Type, Raw Material (Pig Meat, Bovine Meat, Bone, Hydroxypropyl Methylcellulose, and Others), Functionality, Therapeutic Application, End User, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 143 Pages | 商品交期: 2-3个工作天内

价格

IMARC Group年全球空心胶囊市场规模达31亿美元。确保患者胃肠道安全的胶囊中胶囊技术的日益普及，加上医疗保健行业的众多进步，主要推动了空心胶囊市场的发展。

空心胶囊市场分析：

主要市场驱动因素：慢性病盛行率的增加主要推动全球市场的发展。此外，羟丙基甲基纤维素（HPMC）等非明胶胶囊的采用越来越多，由于其透明、强度适中、耐油和脂肪特性等，也是另一个重要的生长诱导因素。

主要市场趋势：医疗保健行业的主要参与者为引入创新疗法和药物而进行的广泛投资是支撑市场的新兴趋势之一。此外，速释胶囊的开发也对市场成长产生正面影响。

竞争格局：全球市场上一些知名的公司包括 ACG Associated Capsules Pvt. Ltd.、Bright Pharma Caps Inc.、CapsCanada Corporation、HealthCaps India Limited、Lonza Group AG、Medicaps Limited、Qualicaps Co. Ltd.（三菱化学控股株式会社）、Nectar Lifesciences Limited、Roxlor LLC、山西广生药用胶囊有限公司、 Snail Pharma Industry Co. Ltd、Suheung Co. Ltd 和 Sunil Healthcare Limited 等。

地理趋势：由于注重健康的个人越来越倾向于膳食补充剂，北美在市场上表现出明显的主导地位。除此之外，空胶囊供应商和明胶製造商之间的各种策略合作也促进了区域市场的成长。

挑战与机会：空心胶囊市场的主要挑战之一是确保胶囊与各种活性药物成分（API）的稳定性和相容性。然而，材料科学的不断改进，开发创新的胶囊材料和配方，提高稳定性并减少与不同 API 的相互作用，预计将在未来几年推动市场发展。

空心胶囊市场趋势：

慢性病的发生

容易患相关慢性病的老年人口不断增加，对生产治疗有效的胶囊药物的需求不断增加，因为与其他口服剂型相比，胶囊易于吞嚥且溶解时间更快。据世界卫生组织 (WHO) 称，预计 2020 年至 2050 年间，80 岁及以上的人口数量将增加两倍，达到约 4.26 亿。除此之外，据美国人口资料局《人口老化公报》称，到2060 年，65 岁及以上的美国人预计将增加近一倍，从2018 年的5,200 万增加到9,500 万。血管疾病(CVD)在全球范围内非常流行。根据世界卫生组织2019年公布的资料，预计每年有1,790万人因心血管疾病发生率上升而死亡，预计到2030年这一数字将增长至约2,360万人以上。 ，2021 年，英国各地约有760 万人患有心臟病和循环系统疾病。因此，这些病例发病率的上升促进了心血管治疗药物的有效治疗，这为空心胶囊市场前景提供了积极的前景。

新产品发布

製药业先进封装解决方案的引入正在推动市场发展。主要参与者正在开发增强型空胶囊变体，例如 HPMC 胶囊，作为硬明胶胶囊的素食替代品，并满足某些饮食和文化需求。例如，Capsugel 是着名的空胶囊製造商之一，在硬明胶胶囊製造等技术方面拥有 20 多年的经验，提供一系列用于吸入和口服药物应用的羟丙基甲基纤维素 (HPMC) 胶囊。另一个例子是 ACG 于 2022 年 3 月开发的 ACGcaps NTone，它提供源自可食用来源的天然色素选择，吸引了注重健康的个人。此外，Suheung Capsule 是合约 HPMC 和硬明胶胶囊製造服务的主要参与者之一，为製药业提供高度稳定的硬明胶胶囊壳材料。除此之外，欧洲药品管理局（EMA）和美国食品药物管理局（FDA）越来越多的监管批准正在简化新配方的流程，这反过来又是空心胶囊市场的近期机会之一。例如，2020年4月，硬胶囊和製药相关设备製造商之一的Qualicaps在与多家在该地区营运的领先公司签署代理商和分销合作伙伴协议后，扩大了在中东和非洲的业务。同样，2020 年 8 月，Dr. Reddy Laboratories 获得美国 FDA 批准开发仿製青霉胺胶囊，可用于治疗胱胺酸尿症和威尔森氏症。

采用膳食补充剂

胶囊形式的药妆品和营养品（例如 CosmoPod 胶囊和鱼肝油胶囊）越来越受欢迎，它们是重要的生长诱导因素。根据IMARC Group发布的报告，2023年全球营养保健品市场规模达4,685亿美元。 。因此，胶囊形式的补充剂的推出为新配方带来了利润丰厚的机会，从而推动了空胶囊市场的需求。例如，2023 年12 月，总部位于孟买的胶囊製造供应商之一ACG 透过使用并排技术开发了一种新颖的营养保健品设计，将胶囊分成两个隔间，从而使两种不同形式的成分成为可能，例如液体和粉末，製成一粒胶囊。除此之外，膳食补充剂标籤资料库 (DSLD) 的资料显示，大约有 50,000 种膳食补充剂胶囊、软胶囊、片剂、粉末、液体、软糖和包装产品可供选择。这些产品大多是单一维生素、多种维生素、胺基酸、草药、多种矿物质等多种资料。的百分比。这反过来又推动了全球市场。

空心胶囊市场细分：

IMARC Group提供了每个细分市场的主要趋势分析，以及 2024-2032 年全球、区域和国家层面的空心胶囊市场预测。我们的报告根据类型、原材料、功能、治疗应用和最终用户对市场进行了分类。

按类型划分：

明胶胶囊

非明胶胶囊

目前，明胶胶囊占据最大的市场份额

该报告根据类型提供了详细的市场细分和分析。这包括明胶胶囊和非明胶胶囊。根据该报告，明胶胶囊代表了最大的细分市场。

明胶胶囊，也称为凝胶帽，代表了营养保健品和製药行业中使用的一种流行的口服剂量形式，因为它们易于使用、用途广泛，并且能够掩盖封闭物质的不良味道和气味。此外，它们通常有硬质和软质两种形式。硬明胶胶囊广泛用于干燥、粉状成分和丸剂，而软明胶胶囊则非常适合油和液体配方。具有最佳特性（例如改进的稳定性和改进的释放曲线）的明胶胶囊的推出正在促进该领域的成长。例如，Suheung 等公司提供 EMBO CAPS 胶囊，其製造目的是为了优化稳定性。这些胶囊也采用高级原料生产，其中包括来自Suheung子公司Geltech的明胶。此外，严格的规范合规性和电脑化的原料交叉混合确保只有满足确切要求的粉末才能到达胶囊机。除此之外，2023 年 2 月，Vivion, Inc. 推出了多种空明胶胶囊。

按原料划分：

猪肉

牛肉

骨

羟丙基甲基纤维素 (HPMC)

其他的

其中，猪肉在空心胶囊市场份额中表现出明显的主导地位

该报告根据原材料对市场进行了详细的细分和分析。这包括猪肉、牛肉、骨头、羟丙基甲基纤维素 (HPMC) 等。报告称，猪肉是最大的细分市场。

猪肉，特别是猪肉明胶，由于其广泛的可用性和优异的凝胶特性（这对于胶囊製造至关重要）在市场份额中表现出明显的主导地位。猪肉明胶因其稳定的品质和形成坚固且柔韧的胶囊且易于在胃中溶解的能力而受到青睐。例如，Capsugel 在其广泛使用的胶囊中采用了猪肉明胶，从而确保了可靠的性能。此外，2021 年 11 月，国际明胶製造商协会报告称，用于製药应用（包括胶囊）的明胶约 85% 来自猪肉。这种主导地位也是由完善的供应链以及与其他来源（例如牛明胶或鱼明胶）相比较低的猪肉明胶相关生产成本所推动的。儘管由于饮食限制和道德问题，人们对替代来源越来越感兴趣，但猪肉明胶仍然是业界的首选。

按功能划分：

速释胶囊

缓释胶囊

缓释胶囊

目前，速释胶囊占据全球大部分市场份额

该报告根据功能提供了详细的市场细分和分析。这包括速释胶囊、缓释胶囊和缓释胶囊。根据该报告，速释胶囊代表了最大的细分市场。

对需要快速起效的药物的不断增长的需求正在促进这一领域的成长。速释胶囊在胃中快速溶解，迅速释放其内容物，从而实现快速治疗效果，这使得它们成为各种药品和营养保健品的理想选择。例如，2022 年 8 月，ACG 推出了速释胶囊系列 ACGcaps IR，该胶囊专门用于优化活性成分的释放曲线，提高其功效和患者依从性。同样，2023 年 1 月，Capsugel 推出了具有立即释放特性的 Vcaps Plus 胶囊，专为高速填充过程量身定制，并确保快速溶解和生物利用度。这些创新满足了对有效和速效药物不断增长的需求，从而提高了空胶囊市场的近期价格。

依治疗应用分解：

抗生素和抗菌药物

维生素和膳食补充剂

抗酸剂和抗胀气製剂

心血管治疗药物

其他的

该报告根据治疗应用提供了详细的市场细分和分析。这包括抗生素和抗菌药物、维生素和膳食补充剂、抗酸剂和抗胀气製剂、心血管治疗药物等。

由于胶囊易于吞嚥且剂型可控，因此在阿莫西林等抗生素中越来越多地使用胶囊，有助于提高患者的依从性。此外，在消费者对健康和保健日益关注的推动下，维生素和膳食补充剂也占据了很大一部分市场。胶囊提供了一种便捷的方式来消耗必需营养素，例如 Omega-3 脂肪酸和维生素 D（这些物质通常以胶囊形式存在）。抗酸剂和抗气胀製剂可受益于胶囊能够快速缓解消化问题的能力。在心血管治疗中，它们确保准确地输送他汀类药物和抗高血压药物，这对于治疗慢性心臟病至关重要。除此之外，其他治疗领域，包括疼痛管理和荷尔蒙治疗，都利用胶囊的多功能性和药物传递功效，预计这将在未来几年增加空胶囊市场的收入。

按最终用户划分：

医药行业

保健品业

化妆品产业

其他的

目前，医药产业占全球大部分市场份额

该报告提供了基于最终用户的详细市场细分和分析。这包括製药业、营养保健品业、化妆品业等。报告称，製药业是最大的细分行业。

根据空胶囊市场统计数据，对患者友善的给药方式不断增长的需求正在刺激市场。空胶囊为封装各种类型的药物（从粉末和颗粒到液体和半固体）提供了可靠的形式。例如，2023 年 9 月，Lonza 报告称，由于其 Capsugel 硬明胶胶囊在新型药物配方和临床试验中的使用，其需求显着增加。这些胶囊因其一致的性能以及与多种活性药物成分 (API) 的兼容性而受到青睐。同样，Qualicaps 开发了新的 Quali-G 硬明胶胶囊系列，该胶囊专为需要精确剂量和增强稳定性的高效药物而设计。製药业的主要参与者也利用空胶囊进行控释製剂，提高治疗效果和患者遵从性。

按地区划分：

北美洲

美国

加拿大

亚太

中国

日本

印度

韩国

澳洲

印尼

其他的

欧洲

德国

法国

英国

义大利

西班牙

俄罗斯

其他的

拉丁美洲

巴西

墨西哥

其他的

中东和非洲

从空心胶囊市场概况来看，北美目前主导全球市场份额

市场研究报告还对所有主要区域市场进行了全面分析，其中包括北美（美国和加拿大）；亚太地区（中国、日本、印度、韩国、澳洲、印尼等）；欧洲（德国、法国、英国、义大利、西班牙、俄罗斯等）；拉丁美洲（巴西、墨西哥等）；以及中东和非洲。报告称，北美占据最大的市场份额。

慢性病发病率的增加以及美国老年人口的增加正在刺激该地区市场。根据美国人口资料局的人口老化公报，预计到2060 年，65 岁及以上的人口数量将从2018 年的5,200 万增加到9,500 万，几乎翻倍。不断增加营养製剂也是另一个重要的生长诱导因子。根据 CRN 消费者调查，77% 的美国人表示在 2019 年食用了膳食补充剂。 。除此之外，加拿大结构良好的医疗保健系统也鼓励对研发活动的投资，预计这将在预测期内推动北美空胶囊市场的发展。

本报告回答的关键问题

  • 2023年全球空心胶囊市场规模有多大？
  • 2024-2032年全球空心胶囊市场的预期成长率是多少？
  • 推动全球空心胶囊市场的关键因素是什么？
  • COVID-19 对全球空胶囊市场有何影响？
  • 全球空心胶囊市场按类型划分是怎样的？
  • 全球空心胶囊市场依原料划分是怎样的？
  • 根据功能，全球空心胶囊市场的细分情况如何？
  • 基于最终用户的全球空心胶囊市场的细分情况如何？
  • 全球空心胶囊市场的关键区域有哪些？
  • 全球空心胶囊市场的主要参与者/公司有哪些？

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 资料来源
    • 主要资源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球空心胶囊市场

  • 市场概况
  • 市场业绩
  • COVID-19 的影响
  • 市场预测

第 6 章：市场区隔：按类型

  • 明胶胶囊
    • 市场走向
    • 市场预测
  • 非明胶胶囊
    • 市场走向
    • 市场预测

第 7 章：市场区隔：依原料

  • 猪肉
    • 市场走向
    • 市场预测
  • 牛肉
    • 市场走向
    • 市场预测
  • 骨
    • 市场走向
    • 市场预测
  • 羟丙基甲基纤维素 (HPMC)
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 8 章：市场区隔：按功能

  • 速释胶囊
    • 市场走向
    • 市场预测
  • 缓释胶囊
    • 市场走向
    • 市场预测
  • 缓释胶囊
    • 市场走向
    • 市场预测

第 9 章：市场区隔：依治疗应用分类

  • 抗生素和抗菌药物
    • 市场走向
    • 市场预测
  • 维生素和膳食补充剂
    • 市场走向
    • 市场预测
  • 抗酸剂和抗胀气製剂
    • 市场走向
    • 市场预测
  • 心血管治疗药物
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 10 章：市场区隔：依最终用户

  • 医药行业
    • 市场走向
    • 市场预测
  • 保健品业
    • 市场走向
    • 市场预测
  • 化妆品产业
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 11 章：市场区隔：按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 市场走向
    • 市场细分：按国家/地区
    • 市场预测

第 12 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 13 章：价值链分析

第 14 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 15 章：价格分析

第16章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • ACG Associated Capsules Pvt. Ltd.
    • Bright Pharma Caps Inc.
    • CapsCanada Corporation
    • HealthCaps India Limited
    • Lonza Group AG
    • Medicaps Limited
    • Qualicaps Co. Ltd. (Mitsubishi Chemical Holdings Corporation)
    • Nectar Lifesciences Limited
    • Roxlor LLC
    • Shanxi Guangsheng Medicinal Capsules Co. Ltd
    • Snail Pharma Industry Co. Ltd
    • Suheung Co. Ltd
    • Sunil Healthcare Limited
Product Code: SR112024A5187

The global empty capsules market size reached US$ 3.1 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 5.5 Billion by 2032, exhibiting a growth rate (CAGR) of 6.6% during 2024-2032. The emerging popularity of capsule-in-capsule technology to ensure the gastrointestinal safety of patients, coupled with numerous advancements in the healthcare industry, are primarily fueling the empty capsules market.

Empty Capsules Market Analysis:

Major Market Drivers: The increasing prevalence of chronic diseases is primarily driving the global market. Moreover, the rising adoption of non-gelatin capsules, such as hydroxypropyl methylcellulose (HPMC), due to its transparency, moderate strength, resistance to oil and fat properties, etc., is also acting as another significant growth-inducing factor.

Key Market Trends: The widespread investments by key players in the healthcare sector for introducing innovative therapeutics and pharmaceutical drugs are among the emerging trends bolstering the market. Furthermore, the development of immediate-release capsules is also positively influencing the market growth.

Competitive Landscape: Some of the prominent companies in the global market include ACG Associated Capsules Pvt. Ltd., Bright Pharma Caps Inc., CapsCanada Corporation, HealthCaps India Limited, Lonza Group AG, Medicaps Limited, Qualicaps Co. Ltd. (Mitsubishi Chemical Holdings Corporation), Nectar Lifesciences Limited, Roxlor LLC, Shanxi Guangsheng Medicinal Capsules Co. Ltd, Snail Pharma Industry Co. Ltd, Suheung Co. Ltd, and Sunil Healthcare Limited, among many others.

Geographical Trends: North America exhibits a clear dominance in the market, owing to the increasing inclination among health-conscious individuals towards dietary supplements. Besides this, various strategic collaborations between empty capsule suppliers and gelatin manufacturers are contributing to the growth of the regional market.

Challenges and Opportunities: One of the major challenges in the empty capsules market is ensuring the stability and compatibility of capsules with a wide range of active pharmaceutical ingredients (APIs). However, continuous improvements in material science to develop innovative capsule materials and formulations that enhance stability and reduce interactions with diverse APIs are expected to fuel the market in the coming years.

Empty Capsules Market Trends:

Occurrence of Chronic Diseases

The expanding geriatric population who are susceptible to developing associated chronic conditions is escalating the demand for the production of therapeutically effective medicines in the form of capsules, as they are easy to swallow and have faster dissolution times compared to other oral dosage forms. According to the World Health Organization (WHO), the number of individuals aged 80 years or older is anticipated to triple between 2020 and 2050, reaching roughly about 426 million. Besides this, as stated by the Population Reference Bureau's Population Bulletin-Aging in the United States, the Americans aged 65 years and older are expected to nearly double from 52 million in 2018 to 95 million by 2060. Additionally, cardiovascular diseases (CVDs) are highly prevalent globally. As per the data published by the World Health Organization in 2019, an estimated 17.9 million people die each year due to the elevating incidences of cardiovascular diseases, and the number is projected to grow approximately to more than 23.6 million by 2030. Moreover, according to the British Heart Foundation Centre, around 7.6 million individuals were living with heart and circulatory diseases in 2021 across the United Kingdom. As a result, the rising incidences of these cases are bolstering the adoption of cardiovascular therapy drugs for effective treatment, which is providing a positive empty capsules market outlook.

Novel Product Launches

The introduction of advanced encapsulation solutions in the pharmaceutical industry is fueling the market. Key players are developing enhanced empty capsule variants, such as HPMC capsules, that serve as vegetarian alternatives to hard gelatin capsules and satisfy certain dietary and cultural needs. For example, Capsugel, one of the prominent empty capsules manufacturers with more than 20 years of experience in hard gelatin capsule manufacturing, amongst other technologies, provides a range of hydroxy propyl methyl cellulose (HPMC) capsules for inhalation and oral pharmaceutical applications. Another instance is the development of ACGcaps NTone by ACG in March 2022, which offers natural color options derived from edible sources, appealing to health-conscious individuals. Moreover, Suheung Capsule, one of the key players in contract HPMC and hard gelatin capsule manufacturing services, offers highly stable hard gelatin capsule shell materials for the pharmaceutical industry. Apart from this, the increasing number of regulatory approvals from the European Medicines Agency (EMA) and the U.S. Food and Drug Administration (FDA) are simplifying the process of new formulations, which, in turn, is one of the empty capsules market recent opportunities. For example, in April 2020, Qualicaps, one of the manufacturers of hard capsules and pharmaceutical-related equipment, expanded its presence in the Middle East and Africa after signing agency and distribution partnership agreements with a number of leading companies operating in the region. Similarly, in August 2020, Dr. Reddy Laboratories received USFDA approval for the development of generic Penicillamine capsules that can be used for the treatment of cystinuria and Wilson's disease.

Adoption of Dietary Supplements

The inflating popularity of cosmeceuticals and nutraceuticals that are preferred in capsule forms, such as CosmoPod capsules and cod liver oil capsules, respectively, is acting as a significant growth-inducing factor. According to the report published by IMARC, the global nutraceuticals market size reached US$ 468.5 Billion in 2023. Looking forward, IMARC Group anticipated the market to reach US$ 856.3 Billion by 2032, exhibiting a growth rate (CAGR) of 6.7% during 2024-2032. Consequently, the introduction of supplements in the form of capsules that allow lucrative opportunities for new formulations is propelling the empty capsules market demand. For instance, in December 2023, ACG, one of the Mumbai-based capsule manufacturing providers, developed a novel design for nutraceuticals by using side by sides technology that separates capsules into two compartments, thereby enabling ingredients of two different forms, such as liquid and powder, to be made into one capsule. Apart from this, the data from the Dietary Supplements Label Database (DSLD) revealed that roughly 50,000 dietary supplement capsules, softgel, tablet, powder, liquid, gummy, and packet products are available. Most of these products are numerous dosage forms of single vitamins, multi-vitamins, amino acids, herbals, multi-minerals, etc. Moreover, the DSLD data stated that more than 17,000 products are available as capsules under several categories, accounting for a 34 % share among all dosage forms. This, in turn, is driving the global market.

Empty Capsules Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with the empty capsules market forecast at the global, regional, and country levels for 2024-2032. Our report has categorized the market based on the type, raw material, functionality, therapeutic application, and end user.

Breakup by Type:

Gelatin Capsule

Non-gelatin Capsule

Currently, gelatin capsule accounts for the largest market share

The report has provided a detailed breakup and analysis of the market based on the type. This includes gelatin capsule and non-gelatin capsule. According to the report, gelatin capsule represented the largest segmentation.

Gelatin capsules, also called gel caps, represent a popular form of oral dosage used in the nutraceutical and pharmaceutical industries due to their ease of use, versatility, and ability to mask unpleasant tastes and odors of enclosed substances. Moreover, they are commonly available in both hard and soft forms. Hard gelatin capsules are widely used for dry, powdered ingredients and pellets, while soft gelatin capsules are ideal for oils and liquid-based formulations. The introduction of gelatin capsules with optimal properties, such as improved stability and modified release profiles, is augmenting the segment's growth. For instance, companies, such as Suheung, offer EMBO CAPS capsules that are manufactured to optimize stability. These capsules are also produced by adopting high-grade raw materials, including gelatine, which is sourced from Geltech, a subsidiary of Suheung. In addition, stringent specification compliance and computerized raw material cross-blending ensure only powders that meet the exact requirements can reach the capsulation machines. Apart from this, in February 2023, Vivion, Inc. introduced a wide range of empty gelatin capsules.

Breakup by Raw Material:

Pig Meat

Bovine Meat

Bone

Hydroxypropyl Methylcellulose (HPMC)

Others

Among these, pig meat exhibits a clear dominance in the empty capsules market share

The report has provided a detailed breakup and analysis of the market based on the raw material. This includes pig meat, bovine meat, bone, hydroxypropyl methylcellulose (HPMC), and others. According to the report, pig meat represented the largest segmentation.

Pig meat, specifically pork-derived gelatin, exhibits a clear dominance in the market share, owing to its widespread availability and excellent gelling properties, which are crucial for capsule manufacturing. Pork gelatin is favored for its consistent quality and ability to form strong and flexible capsules that dissolve readily in the stomach. For example, Capsugel adopts pork-derived gelatin in their widely used capsules, thereby ensuring reliable performance. Additionally, in November 2021, the International Gelatin Manufacturers Association reported that approximately 85% of the gelatin used in pharmaceutical applications, including capsules, is derived from pork. This dominance is also driven by the well-established supply chains and lower production costs associated with pork gelatin compared to other sources, such as bovine or fish gelatin. Despite the growing interest in alternative sources due to dietary restrictions and ethical concerns, pork gelatin remains the preferred choice in the industry.

Breakup by Functionality:

Immediate-release Capsules

Sustained-release Capsules

Delayed-release Capsules

Currently, immediate-release capsules account for the majority of the global market share

The report has provided a detailed breakup and analysis of the market based on the functionality. This includes immediate-release capsules, sustained-release capsules, and delayed-release capsules. According to the report, immediate-release capsules represented the largest segmentation.

The inflating need for delivering medications that require rapid onset of action is augmenting the growth in this segment. Immediate-release capsules dissolve quickly in the stomach, releasing their contents promptly for fast therapeutic effects, which makes them ideal for a broad range of pharmaceutical and nutraceutical products. For example, in August 2022, ACG launched its line of immediate-release capsules, ACGcaps IR, which are specifically designed to optimize the release profile of active ingredients, enhancing their efficacy and patient compliance. Similarly, in January 2023, Capsugel introduced their Vcaps Plus capsules with immediate-release properties, tailored for high-speed filling processes and ensuring quick dissolution and bioavailability. These innovations cater to the escalating demand for effective and fast-acting medications, which is elevating the empty capsules market's recent price.

Breakup by Therapeutic Application:

Antibiotic and Antibacterial Drugs

Vitamins and Dietary Supplements

Antacid and Antiflatulent Preparations

Cardiovascular Therapy Drugs

Others

The report has provided a detailed breakup and analysis of the market based on therapeutic application. This includes antibiotic and antibacterial drugs, vitamins and dietary supplements, antacid and antiflatulent preparations, cardiovascular therapy drugs, and others.

The rising usage of capsules in antibiotics like amoxicillin helps to improve patient adherence due to their ease of swallowing and controlled dosage forms. Additionally, vitamins and dietary supplements also comprise a large portion of the market, driven by the growing consumer focus on health and wellness. Capsules offer a convenient way to consume essential nutrients, such as omega-3 fatty acids and vitamin D, which are often found in capsule form. Antacid and antiflatulent preparations benefit from the ability of capsules to deliver fast-acting relief from digestive issues. In cardiovascular therapy, they ensure the accurate delivery of drugs like statins and antihypertensives, which are crucial for managing chronic heart conditions. Besides this, other therapeutic areas, including pain management and hormonal therapies, utilize capsules for their versatility and efficacy in drug delivery, which is expected to bolster the empty capsules market revenue in the coming years.

Breakup by End User:

Pharmaceutical Industry

Nutraceutical Industry

Cosmetics Industry

Others

Currently, the pharmaceutical industry account for the majority of the global market share

The report has provided a detailed breakup and analysis of the market based on the end user. This includes pharmaceutical industry, nutraceutical industry, cosmetics industry, and others. According to the report, the pharmaceutical industry represented the largest segmentation.

As per the empty capsules market statistics, the escalating demand for patient-friendly delivery methods is stimulating the market. Empty capsules provide a reliable form for encapsulating various types of medications, from powders and granules to liquids and semisolids. For instance, in September 2023, Lonza reported a significant increase in demand for its Capsugel hard gelatin capsules, driven by their use in novel drug formulations and clinical trials. These capsules are favored for their consistent performance and compatibility with a wide range of active pharmaceutical ingredients (APIs). Similarly, Qualicaps developed its new line of Quali-G hard gelatin capsules, which is designed specifically for high-potency drugs, which require precise dosing and enhanced stability. Key players in the pharmaceutical industry also leverage empty capsules for controlled-release formulations, enhancing therapeutic efficacy and patient compliance.

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

According to the empty capsules market overview, North America currently dominates the global market share

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

The increasing incidences of chronic diseases, along with the expanding geriatric population in the United States, are stimulating the regional market. According to the Population Reference Bureau's Population Bulletin-Aging in the United States, the number of individuals aged 65 years and older is expected to nearly double from 52 million in 2018 to 95 million by 2060. Besides this, the escalating demand for capsule-based nutraceutical formulations is also acting as another significant growth-inducing factor. As per the CRN Consumer Survey, 77% of Americans reported consuming dietary supplements in 2019. Moreover, the survey revealed that vitamins and minerals were the most common supplements consumed by the population across the United States in the same year, accounting for 76% of total dietary supplement consumption. Apart from this, the well-structured healthcare systems in Canada are also encouraging investments in R&D activities, which are anticipated to fuel the empty capsules market in North America over the forecasted period.

Competitive Landscape:

The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major empty capsules market companies have also been provided. Some of the key players in the market include:

ACG Associated Capsules Pvt. Ltd.

Bright Pharma Caps Inc.

CapsCanada Corporation

HealthCaps India Limited

Lonza Group AG

Medicaps Limited

Qualicaps Co. Ltd. (Mitsubishi Chemical Holdings Corporation)

Nectar Lifesciences Limited

Roxlor LLC

Shanxi Guangsheng Medicinal Capsules Co. Ltd

Snail Pharma Industry Co. Ltd

Suheung Co. Ltd

Sunil Healthcare Limited

(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)

Empty Capsules Market Recent Developments:

May 2024: Roquette, one of the global leaders in pharmaceutical and nutraceutical excipients, developed its LYCAGEL Flex hydroxypropyl pea starch premix for nutraceutical and pharmaceutical softgel capsules.

April 2024: Lupin Ltd launched the first generic version of doxycycline capsules, Oracea, in the United States after receiving approval from the U.S. FDA.

February 2023: Vivion, Inc., one of the brands of the Operio Group, announced the introduction of optimal product ranges of empty gelatin, HPMC, and pullulan capsules.

December 2023: One of the health brands of Darling Ingredients, Rousselot, received a U.S. Patent for gelatin technology that improves soft gel capsule stability and efficacy.

Key Questions Answered in This Report

  • 1. What was the size of the global empty capsules market in 2023?
  • 2. What is the expected growth rate of the global empty capsules market during 2024-2032?
  • 3. What are the key factors driving the global empty capsules market?
  • 4. What has been the impact of COVID-19 on the global empty capsules market?
  • 5. What is the breakup of the global empty capsules market based on the type?
  • 6. What is the breakup of the global empty capsules market based on the raw material?
  • 7. What is the breakup of the global empty capsules market based on the functionality?
  • 8. What is the breakup of the global empty capsules market based on the end user?
  • 9. What are the key regions in the global empty capsules market?
  • 10. Who are the key players/companies in the global empty capsules market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Empty Capsules Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Gelatin Capsule
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Non-gelatin Capsule
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Raw Material

  • 7.1 Pig Meat
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Bovine Meat
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Bone
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Hydroxypropyl Methylcellulose (HPMC)
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by Functionality

  • 8.1 Immediate-release Capsules
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Sustained-release Capsules
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Delayed-release Capsules
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Therapeutic Application

  • 9.1 Antibiotic and Antibacterial Drugs
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Vitamins and Dietary Supplements
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Antacid and Antiflatulent Preparations
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Cardiovascular Therapy Drugs
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast
  • 9.5 Others
    • 9.5.1 Market Trends
    • 9.5.2 Market Forecast

10 Market Breakup by End User

  • 10.1 Pharmaceutical Industry
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 Nutraceutical Industry
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast
  • 10.3 Cosmetics Industry
    • 10.3.1 Market Trends
    • 10.3.2 Market Forecast
  • 10.4 Others
    • 10.4.1 Market Trends
    • 10.4.2 Market Forecast

11 Market Breakup by Region

  • 11.1 North America
    • 11.1.1 United States
      • 11.1.1.1 Market Trends
      • 11.1.1.2 Market Forecast
    • 11.1.2 Canada
      • 11.1.2.1 Market Trends
      • 11.1.2.2 Market Forecast
  • 11.2 Asia-Pacific
    • 11.2.1 China
      • 11.2.1.1 Market Trends
      • 11.2.1.2 Market Forecast
    • 11.2.2 Japan
      • 11.2.2.1 Market Trends
      • 11.2.2.2 Market Forecast
    • 11.2.3 India
      • 11.2.3.1 Market Trends
      • 11.2.3.2 Market Forecast
    • 11.2.4 South Korea
      • 11.2.4.1 Market Trends
      • 11.2.4.2 Market Forecast
    • 11.2.5 Australia
      • 11.2.5.1 Market Trends
      • 11.2.5.2 Market Forecast
    • 11.2.6 Indonesia
      • 11.2.6.1 Market Trends
      • 11.2.6.2 Market Forecast
    • 11.2.7 Others
      • 11.2.7.1 Market Trends
      • 11.2.7.2 Market Forecast
  • 11.3 Europe
    • 11.3.1 Germany
      • 11.3.1.1 Market Trends
      • 11.3.1.2 Market Forecast
    • 11.3.2 France
      • 11.3.2.1 Market Trends
      • 11.3.2.2 Market Forecast
    • 11.3.3 United Kingdom
      • 11.3.3.1 Market Trends
      • 11.3.3.2 Market Forecast
    • 11.3.4 Italy
      • 11.3.4.1 Market Trends
      • 11.3.4.2 Market Forecast
    • 11.3.5 Spain
      • 11.3.5.1 Market Trends
      • 11.3.5.2 Market Forecast
    • 11.3.6 Russia
      • 11.3.6.1 Market Trends
      • 11.3.6.2 Market Forecast
    • 11.3.7 Others
      • 11.3.7.1 Market Trends
      • 11.3.7.2 Market Forecast
  • 11.4 Latin America
    • 11.4.1 Brazil
      • 11.4.1.1 Market Trends
      • 11.4.1.2 Market Forecast
    • 11.4.2 Mexico
      • 11.4.2.1 Market Trends
      • 11.4.2.2 Market Forecast
    • 11.4.3 Others
      • 11.4.3.1 Market Trends
      • 11.4.3.2 Market Forecast
  • 11.5 Middle East and Africa
    • 11.5.1 Market Trends
    • 11.5.2 Market Breakup by Country
    • 11.5.3 Market Forecast

12 SWOT Analysis

  • 12.1 Overview
  • 12.2 Strengths
  • 12.3 Weaknesses
  • 12.4 Opportunities
  • 12.5 Threats

13 Value Chain Analysis

14 Porters Five Forces Analysis

  • 14.1 Overview
  • 14.2 Bargaining Power of Buyers
  • 14.3 Bargaining Power of Suppliers
  • 14.4 Degree of Competition
  • 14.5 Threat of New Entrants
  • 14.6 Threat of Substitutes

15 Price Analysis

16 Competitive Landscape

  • 16.1 Market Structure
  • 16.2 Key Players
  • 16.3 Profiles of Key Players
    • 16.3.1 ACG Associated Capsules Pvt. Ltd.
      • 16.3.1.1 Company Overview
      • 16.3.1.2 Product Portfolio
    • 16.3.2 Bright Pharma Caps Inc.
      • 16.3.2.1 Company Overview
      • 16.3.2.2 Product Portfolio
    • 16.3.3 CapsCanada Corporation
      • 16.3.3.1 Company Overview
      • 16.3.3.2 Product Portfolio
    • 16.3.4 HealthCaps India Limited
      • 16.3.4.1 Company Overview
      • 16.3.4.2 Product Portfolio
    • 16.3.5 Lonza Group AG
      • 16.3.5.1 Company Overview
      • 16.3.5.2 Product Portfolio
      • 16.3.5.3 Financials
      • 16.3.5.4 SWOT Analysis
    • 16.3.6 Medicaps Limited
      • 16.3.6.1 Company Overview
      • 16.3.6.2 Product Portfolio
      • 16.3.6.3 Financials
    • 16.3.7 Qualicaps Co. Ltd. (Mitsubishi Chemical Holdings Corporation)
      • 16.3.7.1 Company Overview
      • 16.3.7.2 Product Portfolio
    • 16.3.8 Nectar Lifesciences Limited
      • 16.3.8.1 Company Overview
      • 16.3.8.2 Product Portfolio
      • 16.3.8.3 Financials
    • 16.3.9 Roxlor LLC
      • 16.3.9.1 Company Overview
      • 16.3.9.2 Product Portfolio
    • 16.3.10 Shanxi Guangsheng Medicinal Capsules Co. Ltd
      • 16.3.10.1 Company Overview
      • 16.3.10.2 Product Portfolio
    • 16.3.11 Snail Pharma Industry Co. Ltd
      • 16.3.11.1 Company Overview
      • 16.3.11.2 Product Portfolio
    • 16.3.12 Suheung Co. Ltd
      • 16.3.12.1 Company Overview
      • 16.3.12.2 Product Portfolio
    • 16.3.13 Sunil Healthcare Limited
      • 16.3.13.1 Company Overview
      • 16.3.13.2 Product Portfolio
      • 16.3.13.3 Financials

List of Figures

  • Figure 1: Global: Empty Capsules Market: Major Drivers and Challenges
  • Figure 2: Global: Empty Capsules Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Empty Capsules Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Empty Capsules Market: Breakup by Type (in %), 2023
  • Figure 5: Global: Empty Capsules Market: Breakup by Raw Material (in %), 2023
  • Figure 6: Global: Empty Capsules Market: Breakup by Functionality (in %), 2023
  • Figure 7: Global: Empty Capsules Market: Breakup by Therapeutic Application (in %), 2023
  • Figure 8: Global: Empty Capsules Market: Breakup by End User (in %), 2023
  • Figure 9: Global: Empty Capsules Market: Breakup by Region (in %), 2023
  • Figure 10: Global: Empty Capsules (Gelatin Capsule) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Empty Capsules (Gelatin Capsule) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Empty Capsules (Non-gelatin Capsule) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Empty Capsules (Non-gelatin Capsule) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Empty Capsules (Pig Meat) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Empty Capsules (Pig Meat) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Empty Capsules (Bovine Meat) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Empty Capsules (Bovine Meat) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Empty Capsules (Bone) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Empty Capsules (Bone) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Empty Capsules (Hydroxypropyl Methylcellulose-HPMC) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Empty Capsules (Hydroxypropyl Methylcellulose-HPMC) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Empty Capsules (Other Raw Materials) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Empty Capsules (Other Raw Materials) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Empty Capsules (Immediate-release Capsules) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Empty Capsules (Immediate-release Capsules) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: Empty Capsules (Sustained-release Capsules) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: Empty Capsules (Sustained-release Capsules) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Global: Empty Capsules (Delayed-release Capsules) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Global: Empty Capsules (Delayed-release Capsules) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: Global: Empty Capsules (Antibiotic and Antibacterial Drugs) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: Global: Empty Capsules (Antibiotic and Antibacterial Drugs) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: Global: Empty Capsules (Vitamins and Dietary Supplements) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: Global: Empty Capsules (Vitamins and Dietary Supplements) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: Global: Empty Capsules (Antacid and Antiflatulent Preparations) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: Global: Empty Capsules (Antacid and Antiflatulent Preparations) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: Global: Empty Capsules (Cardiovascular Therapy Drugs) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: Global: Empty Capsules (Cardiovascular Therapy Drugs) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: Global: Empty Capsules (Other Therapeutic Applications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: Global: Empty Capsules (Other Therapeutic Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: Global: Empty Capsules (Pharmaceutical Industry) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: Global: Empty Capsules (Pharmaceutical Industry) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: Global: Empty Capsules (Nutraceutical Industry) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: Global: Empty Capsules (Nutraceutical Industry) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: Global: Empty Capsules (Cosmetics Industry) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: Global: Empty Capsules (Cosmetics Industry) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: Global: Empty Capsules (Other End Users) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: Global: Empty Capsules (Other End Users) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: North America: Empty Capsules Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: North America: Empty Capsules Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: United States: Empty Capsules Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: United States: Empty Capsules Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: Canada: Empty Capsules Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: Canada: Empty Capsules Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: Asia-Pacific: Empty Capsules Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: Asia-Pacific: Empty Capsules Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: China: Empty Capsules Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: China: Empty Capsules Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: Japan: Empty Capsules Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: Japan: Empty Capsules Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: India: Empty Capsules Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: India: Empty Capsules Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: South Korea: Empty Capsules Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: South Korea: Empty Capsules Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Australia: Empty Capsules Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: Australia: Empty Capsules Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Indonesia: Empty Capsules Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: Indonesia: Empty Capsules Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Others: Empty Capsules Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Others: Empty Capsules Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Europe: Empty Capsules Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Europe: Empty Capsules Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Germany: Empty Capsules Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Germany: Empty Capsules Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: France: Empty Capsules Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 75: France: Empty Capsules Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 76: United Kingdom: Empty Capsules Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 77: United Kingdom: Empty Capsules Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 78: Italy: Empty Capsules Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 79: Italy: Empty Capsules Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 80: Spain: Empty Capsules Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 81: Spain: Empty Capsules Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 82: Russia: Empty Capsules Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 83: Russia: Empty Capsules Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 84: Others: Empty Capsules Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 85: Others: Empty Capsules Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 86: Latin America: Empty Capsules Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 87: Latin America: Empty Capsules Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 88: Brazil: Empty Capsules Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 89: Brazil: Empty Capsules Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 90: Mexico: Empty Capsules Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 91: Mexico: Empty Capsules Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 92: Others: Empty Capsules Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 93: Others: Empty Capsules Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 94: Middle East and Africa: Empty Capsules Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 95: Middle East and Africa: Empty Capsules Market: Breakup by Country (in %), 2023
  • Figure 96: Middle East and Africa: Empty Capsules Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 97: Global: Empty Capsules Industry: SWOT Analysis
  • Figure 98: Global: Empty Capsules Industry: Value Chain Analysis
  • Figure 99: Global: Empty Capsules Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Empty Capsules Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Empty Capsules Market Forecast: Breakup by Type (in Million US$), 2024-2032
  • Table 3: Global: Empty Capsules Market Forecast: Breakup by Raw Material (in Million US$), 2024-2032
  • Table 4: Global: Empty Capsules Market Forecast: Breakup by Functionality (in Million US$), 2024-2032
  • Table 5: Global: Empty Capsules Market Forecast: Breakup by Therapeutic Application (in Million US$), 2024-2032
  • Table 6: Global: Empty Capsules Market Forecast: Breakup by End User (in Million US$), 2024-2032
  • Table 7: Global: Empty Capsules Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 8: Global: Empty Capsules Market: Competitive Structure
  • Table 9: Global: Empty Capsules Market: Key Players